The research was conducted by The Scripps Research Institute (TSRI) in San Diego, California, where lab workers first tested their hypothesis against rhinovirus, most notorious for causing the common cold. “This is really a form of cellular vaccination,” said study senior author Dr. Richard Lerner, Professor of Immunochemistry at TSRI.
From 2005 to 2014, the annual number of new HIV diagnoses dropped by 19 per cent, but the disease is still an issue. In the U.S. alone, more than 1.2 million people are living with the virus and one in eight patients doesn’t even know it.
This article was originally published on MensHealth.com